Metoprolol tartrate and Eosinophilia - a phase IV clinical study of FDA data

Summary:

Eosinophilia is reported as a side effect among people who take Metoprolol tartrate (metoprolol tartrate), especially for people who are male, 60+ old, have been taking the drug for 5 - 10 years also take Aspirin, and have Acute coronary syndrome.

The phase IV clinical study analyzes which people have Eosinophilia when taking Metoprolol tartrate. It is created by eHealthMe based on reports of 83,460 people who have side effects when taking Metoprolol tartrate from the FDA, and is updated regularly.

What is Metoprolol tartrate?

Metoprolol tartrate has active ingredients of metoprolol tartrate. It is often used in high blood pressure. eHealthMe is studying from 89,747 Metoprolol tartrate users. Check the latest studies of Metoprolol tartrate.

What is Eosinophilia?

Eosinophilia (eosinophil count in the peripheral blood exceeds) is found to be associated with 955 drugs and 1,395 conditions by eHealthMe. Check the latest studies of Eosinophilia.

On Aug, 04, 2026

83,460 people reported to have side effects when taking Metoprolol tartrate.
Among them, 44 people (0.05%) have Eosinophilia.

Could Metoprolol tartrate cause Eosinophilia?

Among these 44 people:

How long have people been on Metoprolol tartrate when they have Eosinophilia? *

What is the gender of people who have Eosinophilia when taking Metoprolol tartrate? *

female: 41.86 %
male: 58.14 %

What is the age of people who have Eosinophilia when taking Metoprolol tartrate? *

What are other drugs people take besides Metoprolol tartrate? *

Aspirin: 13 people, 29.55%
Simvastatin: 9 people, 20.45%
Omeprazole: 7 people, 15.91%
Ramipril: 7 people, 15.91%
Clopidogrel Bisulfate: 6 people, 13.64%
Nifedipine: 5 people, 11.36%
Olmesartan Medoxomil: 4 people, 9.09%
Sevelamer Hydrochloride: 4 people, 9.09%
Famotidine: 4 people, 9.09%
Clozapine: 3 people, 6.82%

What are other side effects people have besides Eosinophilia? *

Fever: 6 people, 13.64%
Eosinophilic Pneumonia (eosinophil accumulates in the lung): 6 people, 13.64%
Thrombocytopenia (decrease of platelets in blood): 5 people, 11.36%
Rashes (redness): 5 people, 11.36%
Cardiac Failure: 4 people, 9.09%
Drug Eruption (adverse drug reaction of the skin): 4 people, 9.09%
Itching: 4 people, 9.09%
Autoimmune Thrombocytopenia (isolated low platelet count (thrombocytopenia) with normal bone marrow and the absence of other causes of thrombocytopenia): 3 people, 6.82%
Acute Kidney Failure: 3 people, 6.82%
Pneumonia: 3 people, 6.82%

What are the existing conditions these people have? *

Acute Coronary Syndrome (acute chest pain and other symptoms that happen because the heart does not get blood): 6 people, 13.64%
Multiple Myeloma (cancer of the plasma cells): 3 people, 6.82%
Constipation: 3 people, 6.82%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 4.55%
Nasopharyngitis (inflammation of the nasopharynx): 2 people, 4.55%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 4.55%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 2 people, 4.55%
Pain: 2 people, 4.55%
Essential Hypertension (primary hypertension): 1 person, 2.27%
Hypertensive Heart Disease: 1 person, 2.27%

* Approximation only. Some reports may have incomplete information.

Do you take Metoprolol tartrate and have Eosinophilia?

- Check whether Eosinophilia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Metoprolol tartrate:

Metoprolol tartrate (89,747 reports)

Eosinophilia treatments and more:

Eosinophilia (20,276 reports)

Browse all side effects of Metoprolol tartrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Eosinophilia:

Eosinophilia (955 drugs)

Browse all the conditions that are associated with Eosinophilia:

Eosinophilia (1,395 conditions)

Related publications that referenced our studies

Azuma N, Matsui K, Hashimoto N, Yoshikawa T, Sano H, "Successful Switch to Golimumab for Eosinophilia and Skin Symptoms Related to Multiple Biologics in a Patient with Rheumatoid Arthritis", Internal Medicine, 2017 Jun .
Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .
Guidelli GM, Tenti S, Fioravanti A, "Severe eosinophilia during anti-tumor necrosis factor-alpha therapy for psoriatic arthritis", Indian Journal of Dermatology, Venereology, and Leprology, 2015 Jan .
Malisiewicz B, Murer C, Schmid JP, French LE, Schmid-Grendelmeier P, Navarini AA, "Eosinophilia during psoriasis treatment with TNF antagonists", Dermatology, 2013 Jan .
Azuma N, Matsui K, Hashimoto N, Yoshikawa T, Sano H, "Successful Switch to Golimumab for Eosinophilia and Skin Symptoms Related to Multiple Biologics in a Patient with Rheumatoid Arthritis", Internal Medicine, 2017 Jun .
Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .
Guidelli GM, Tenti S, Fioravanti A, "Severe eosinophilia during anti-tumor necrosis factor-alpha therapy for psoriatic arthritis", Indian Journal of Dermatology, Venereology, and Leprology, 2015 Jan .
Malisiewicz B, Murer C, Schmid JP, French LE, Schmid-Grendelmeier P, Navarini AA, "Eosinophilia during psoriasis treatment with TNF antagonists", Dermatology, 2013 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on metoprolol tartrate (the active ingredients of Metoprolol tartrate) and Metoprolol tartrate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.